TRIL insider transactions
Trillium Therapeutics Inc. (TRIL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TRIL
- SEC Form 4: Walker Paul Edward returned 5,736,363 shares to the company4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Pucci Paolo4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Myers Scott Dunseth4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Harrison Rosemary returned 75 shares to the company, closing all direct ownership in the company4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Beshar Luke M4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Parsons James T.4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Kamarck Michael E.4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Looker Benjamin4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Mackey Catherine J4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Bruns Ingmar4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Petrova Penka4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Uger Robert4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Tayton-Martin Helen Katrina4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Skvarka Jan4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Uger Robert exercised 3,646 units of Common Shares at a strike of $0.30 and sold $32,814 worth of Common Shares (3,646 units at $9.00)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 3 filed by MACKEY CATHERINE J3 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by MACKEY CATHERINE J4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Uger Robert exercised 3,646 units of Common Shares at a strike of $0.32 and sold $30,152 worth of Common Shares (3,646 units at $8.27)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Skvarka Jan exercised 130,500 units of Common Shares at a strike of $0.40 and sold $1,201,683 worth of Common Shares (130,500 units at $9.21)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Uger Robert exercised 3,646 units of Common Shares at a strike of $0.31 and sold $33,908 worth of Common Shares (3,646 units at $9.30)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Looker Benjamin4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4 filed by Myers Scott Dunseth4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 3 filed by Looker Benjamin3 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 3 filed by Myers Scott Dunseth3 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Robert Uger exercised 3,646 units of Common Shares at a strike of $0.30 and sold $39,450 worth of Common Shares (3,646 units at $10.82)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Penka Petrova exercised 5,312 units of Common Shares at a strike of $1.80 and sold $58,910 worth of Common Shares (5,312 units at $11.09)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Robert Uger exercised 2,917 units of Common Shares at a strike of $3.39 and sold $34,916 worth of Common Shares (2,917 units at $11.97)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Penka Petrova exercised 5,312 units of Common Shares at a strike of $1.80 and sold $58,857 worth of Common Shares (5,312 units at $11.08)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Robert Uger exercised 3,646 units of Common Shares at a strike of $0.30 and sold $36,861 worth of Common Shares (3,646 units at $10.11)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Penka Petrova exercised 5,820 units of Common Shares at a strike of $2.46 and sold $74,397 worth of Common Shares (5,820 units at $12.78)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)
- SEC Form 4: Robert Uger exercised 7,147 units of Common Shares at a strike of $2.29 and sold $91,270 worth of Common Shares (7,147 units at $12.77)4 - Trillium Therapeutics Inc. (0001616212) (Issuer)